Circulating miRNAs in myasthenia gravis: miR-150-5p as a new potential biomarker
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circulating miRNAs in myasthenia gravis: miR-150-5p as a new potential biomarker
Authors
Keywords
-
Journal
Annals of Clinical and Translational Neurology
Volume 1, Issue 1, Pages 49-58
Publisher
Wiley
Online
2013-12-31
DOI
10.1002/acn3.24
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circulating MicroRNAs as biomarkers for disease staging in multiple sclerosis
- (2013) Roopali Gandhi et al. ANNALS OF NEUROLOGY
- MicroRNA-21 with therapeutic potential in autoimmune diseases
- (2013) Wang-Dong Xu et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Old and new functions for the adenovirus virus-associated RNAs
- (2013) Tanel Punga et al. Future Virology
- Altered expression of miR-146a in myasthenia gravis
- (2013) Jiayin Lu et al. NEUROSCIENCE LETTERS
- Implication of double-stranded RNA signaling in the etiology of autoimmune myasthenia gravis
- (2012) Perrine Cufi et al. ANNALS OF NEUROLOGY
- Defects of immunoregulatory mechanisms in myasthenia gravis: role of IL-17
- (2012) Angeline Gradolatto et al. Annals of the New York Academy of Sciences
- Biomarker development for myasthenia gravis
- (2012) Henry J. Kaminski et al. Annals of the New York Academy of Sciences
- Circulating MicroRNAs
- (2012) Esther E. Creemers et al. CIRCULATION RESEARCH
- Muscle autoantibodies in myasthenia gravis: beyond diagnosis?
- (2012) Matthew N Meriggioli et al. Expert Review of Clinical Immunology
- Altered let-7 expression in Myasthenia gravis and let-7c mediated regulation of IL-10 by directly targeting IL-10 in Jurkat cells
- (2012) Lin Jiang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- MiR-320a is Downregulated in Patients with Myasthenia Gravis and Modulates Inflammatory Cytokines Production by Targeting Mitogen-activated Protein Kinase 1
- (2012) Zhuoan Cheng et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Human microRNA-27a* targets Prf1 and GzmB expression to regulate NK-cell cytotoxicity
- (2011) T.-D. Kim et al. BLOOD
- Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150
- (2011) M. Ghisi et al. BLOOD
- Silencing of microRNA-21in vivoameliorates autoimmune splenomegaly in lupus mice
- (2011) Barry G. Garchow et al. EMBO Molecular Medicine
- Inhibition of peripheral blood natural killer cell cytotoxicity in patients with myasthenia gravis treated with plasmapheresis
- (2011) P. J. Chien et al. EUROPEAN JOURNAL OF NEUROLOGY
- miR-150 regulates the development of NK and iNKT cells
- (2011) Natalie A. Bezman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- MicroRNA-21 Limits In Vivo Immune Response-Mediated Activation of the IL-12/IFN- Pathway, Th1 Polarization, and the Severity of Delayed-Type Hypersensitivity
- (2011) T. X. Lu et al. JOURNAL OF IMMUNOLOGY
- Differentiation associated regulation of microRNA expression in vivo in human CD8+ T cell subsets
- (2011) Bruno Salaun et al. Journal of Translational Medicine
- Extracellular microRNA: A new source of biomarkers
- (2011) Alton Etheridge et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Non-coding RNAs in human disease
- (2011) Manel Esteller NATURE REVIEWS GENETICS
- Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis
- (2011) Chiara Fenoglio et al. NEUROSCIENCE LETTERS
- The microRNA-21-PDCD4 axis prevents type 1 diabetes by blocking pancreatic cell death
- (2011) Q. Ruan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Thymic remodeling associated with hyperplasia in myasthenia gravis
- (2010) Rozen Le Panse et al. AUTOIMMUNITY
- The MG Composite: A valid and reliable outcome measure for myasthenia gravis
- (2010) T. M. Burns et al. NEUROLOGY
- Post-transcriptional regulation of miR-27 in murine cytomegalovirus infection
- (2010) A. H. Buck et al. RNA
- Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity
- (2009) Matthew N Meriggioli et al. LANCET NEUROLOGY
- A comparison of long-term post-thymectomy outcome of anti-AChR-positive, anti-AChR-negative and anti-MuSK-positive patients with non-thymomatous myasthenia gravis
- (2008) José M Ponseti et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Up on the tightrope: natural killer cell activation and inhibition
- (2008) Lewis L Lanier NATURE IMMUNOLOGY
- Analyzing real-time PCR data by the comparative CT method
- (2008) Thomas D Schmittgen et al. Nature Protocols
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started